Biomics Biopharma logo

BBM - Biomics Biopharma Share Price

n/a 0.0  0.0%

Last Trade -

Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1855
Unlock BBM Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
Balance Sheet
FINANCIAL BRIEF: : Biomics Biopharma Ltd has not disclosed anycomparable financial information.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BBM Revenue Unlock BBM Revenue

Net Income

BBM Net Income Unlock BBM Revenue

Normalised EPS

BBM Normalised EPS Unlock BBM Revenue

PE Ratio Range

BBM PE Ratio Range Unlock BBM Revenue

Dividend Yield Range

BBM Dividend Yield Range Unlock BBM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BBM EPS Forecasts Unlock BBM Revenue
Profile Summary

Biomics Biopharma Limited is a holding company operates through its subsidiary. The Company’s subsidiary Biomics Biotechnologies Co., Ltd, is a near-clinical-stage biopharmaceutical company in developing and commercializing double stranded ribonucleic acid (dsRNA) based products for medical needs. The Company's technology includes Ribonucleic Acid Interference (RNAi) and dsRNA. dsRNA is a key activator of the innate immune response, particularly against viral infections. The innate immune system recognises pathogen-associated molecules using pattern-recognition receptors that activate a wide range of signalling cascades to maintain host defence against infection and inflammation. RNAi is a form of genetic medicine RNAi is a potent methodology for reducingthe expression of genes in vitro and in vivo. It has conducated phase III clinical study. MultisiRNA is a novel siRNA-based anti-HBV therapeutic. The Company’s skincare products include CoSensia, which is a anti-acne essence lotion.

Last Annual January 1st, 1970
Last Interim January 1st, 1970
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Exchange Australian Stock Exchange - SEATS
Shares in Issue
Free Float (0.0%)
Eligible for
BBM Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BBM
Upcoming Events for BBM
Frequently Asked Questions for Biomics Biopharma
What is the Biomics Biopharma share price?

As of , shares in Biomics Biopharma are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Biomics Biopharma share price performed this year?

Shares in Biomics Biopharma are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biomics Biopharma price has moved by % over the past year.

What are the analyst and broker recommendations for Biomics Biopharma?

There are no analysts currently covering Biomics Biopharma.

When will Biomics Biopharma next release its financial results?

It is not known when Biomics Biopharma will next release financial results.

What is the Biomics Biopharma dividend yield?

Biomics Biopharma does not currently pay a dividend.

Does Biomics Biopharma pay a dividend?

Biomics Biopharma does not currently pay a dividend.

When does Biomics Biopharma next pay dividends?

Biomics Biopharma does not currently pay a dividend.

How do I buy Biomics Biopharma shares?

To buy shares in Biomics Biopharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biomics Biopharma?

Shares in Biomics Biopharma are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Biomics Biopharma shares listed? Where are Biomics Biopharma shares listed?

Here are the trading details for Biomics Biopharma:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: BBM
What kind of share is Biomics Biopharma?

We were not able to load our ranking data for Biomics Biopharma

Is there a Biomics Biopharma share price forecast 2021?

We were not able to load any forecast data for Biomics Biopharma.

How can I tell whether the Biomics Biopharma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biomics Biopharma. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Biomics Biopharma are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biomics Biopharma PE Ratio?

We were not able to find PE ratio data for Biomics Biopharma.

Who are the key directors of Biomics Biopharma?

We were unable to find the directors for Biomics Biopharma.

Who are the major shareholders of Biomics Biopharma?

Here are the top five shareholders of Biomics Biopharma based on the size of their shareholding:

Similar to BBM
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.